Status:
COMPLETED
Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The new coronavirus pandemic responsible for the severe acute respiratory syndrome SARS-CoV2 requires, in its severe forms, the use of invasive ventilation in intensive care. The first patients seen ...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient with SARS-CoV2 treated in the intensive care unit of the HPSJ for respiratory distress, using invasive ventilation by oro-tracheal intubation from April 2020
- French speaking patient
Exclusion
- Patient with an alertness disorder with Glasgow eye score \<3 and / or motor \<6 (confusion being a poor criterion for evaluating the Glasgow score apart from head trauma).
- Patient with impossibility to communicate (mutism, aphonia, major language barrier)
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient objecting to the use of his data for this research
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 23 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04468035
Start Date
June 1 2020
End Date
May 23 2022
Last Update
October 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014